Biotech

All Articles

Former Seagen chief executive officer introduces new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was sold to Pfizer in 2014 for a tremendous...

Ironwood produces further purpose $1B GI drug with new subgroup records

.On the heels of a period 3 gain that neglected to excite financiers, Ironwood Pharmaceuticals is ac...

Novartis inks $150M deal for autoimmune molecular glue

.Do not stop Monte Rosa Rehabs right now. The Boston-based biotech is actually having a ball after a...

Jade takes exec staff along with Chinook veterinarians-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, firings an...

Septerna goes public with upsized offering of $288M

.Celebrating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...

AbbVie makes Richter richer, paying $25M to make up breakthrough deal

.AbbVie has returned to the source of its own antipsychotic powerhouse Vraylar searching for yet ano...

GenSight enters final weeks of cash runway as earnings stream squeezes by of reach

.GenSight Biologics is actually full weeks out of lacking loan. Once again. The biotech just possess...

AZ licenses thrown away rare health condition drug to Monopar Therapeutics

.Monopar Therapeutics is recouping a medication coming from the dump of AstraZeneca's rare illness p...

Arcus' brand-new HIF-2a data in kidney cancer cells mention possible upper hand over Merck's Welireg, professionals point out

.With new records out on Arcus Biosciences' experimental HIF-2a prevention, one group of experts est...

Roche wagers up to $1B to increase Dyno gene therapy shipment pact

.After developing a gene treatment alliance along with Dyno Rehabs in 2020, Roche is back for even m...